| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Brian J Fairman, C Debra Furr-Holden, Renee M Johnso. When Marijuana Is Used before Cigarettes or Alcohol: Demographic Predictors and Associations with Heavy Use, Cannabis Use Disorder, and Other Drug-related Outcomes. Prevention science : the official journal of the Society for Prevention Research. vol 20. issue 2. 2020-03-18. PMID:29770947. |
among substance users and adjusting for age of onset and the number of substances used, using marijuana first was associated higher odds of heavy current marijuana use and cud. |
2020-03-18 |
2023-08-13 |
Not clear |
| Brian J Fairman, C Debra Furr-Holden, Renee M Johnso. When Marijuana Is Used before Cigarettes or Alcohol: Demographic Predictors and Associations with Heavy Use, Cannabis Use Disorder, and Other Drug-related Outcomes. Prevention science : the official journal of the Society for Prevention Research. vol 20. issue 2. 2020-03-18. PMID:29770947. |
using marijuana first might increase the chance of heavy use and cud. |
2020-03-18 |
2023-08-13 |
Not clear |
| Morgan M Philbin, Pia M Mauro, Julian Santaella-Tenorio, Christine M Mauro, Elizabeth N Kinnard, Magdalena Cerdá, Silvia S Martin. Associations between state-level policy liberalism, cannabis use, and cannabis use disorder from 2004 to 2012: Looking beyond medical cannabis law status. The International journal on drug policy. vol 65. 2020-03-17. PMID:30685092. |
we explored the association between state-level policy liberalism and past-year cannabis use (cu) and cannabis use disorder (cud). |
2020-03-17 |
2023-08-13 |
Not clear |
| Jin H Yoon, Guadalupe G San Miguel, Jessica N Vincent, Robert Suchting, Ilana Haliwa, Michael F Weaver, Joy M Schmitz, Scott D Lan. Assessing attentional bias and inhibitory control in cannabis use disorder using an eye-tracking paradigm with personalized stimuli. Experimental and clinical psychopharmacology. vol 27. issue 6. 2020-02-26. PMID:30907601. |
individuals with cannabis use disorders (cud) show inhibitory control deficits and differential attention toward marijuana (mj) stimuli. |
2020-02-26 |
2023-08-13 |
human |
| Natalia Estévez-Lamorte, Simon Foster, Dominique Eich-Höchli, Franz Moggi, Gerhard Gmel, Meichun Mohler-Ku. Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: a follow-up study among young men. European archives of psychiatry and clinical neuroscience. vol 269. issue 6. 2020-02-04. PMID:30483874. |
we examined: (1) the contribution of adhd, as assessed at baseline, on the risky use of alcohol, nicotine and cannabis, and their corresponding use disorders (aud, nud, cud) at follow-up; and (2) the association between adhd and the course of outcomes (i.e., absence, initiation, maturing out, persistence) over 15 months. |
2020-02-04 |
2023-08-13 |
Not clear |
| Nathan A Gillespie, Steven H Aggen, Michael C Neale, Gun Peggy Knudsen, Robert F Krueger, Susan C South, Nikolai Czajkowski, Ragnar Nesvåg, Eivind Ystrom, Kenneth S Kendler, Ted Reichborn-Kjenneru. Associations between personality disorders and cannabis use and cannabis use disorder: a population-based twin study. Addiction (Abingdon, England). vol 113. issue 8. 2019-12-09. PMID:29500852. |
our aims were to determine which combination of pds trait scores best predict cannabis use (cu) and cannabis use disorder (cud), and to estimate the size and significance of genetic and environmental risks in pd traits shared with cu and cud. |
2019-12-09 |
2023-08-13 |
Not clear |
| Jack R Cornelius, Levent Kirisc. Assessing TLI as a Predictor of Treatment Seeking for SUD among Youth Transitioning to Young Adulthood. Advances in psychology research. vol 98. 2019-11-20. PMID:25379028. |
our recent work has focuses on subjects with cannabis use disorders (cud), since cud are the most common sud. |
2019-11-20 |
2023-08-13 |
human |
| Jack R Cornelius, Levent Kirisc. Assessing TLI as a Predictor of Treatment Seeking for SUD among Youth Transitioning to Young Adulthood. Advances in psychology research. vol 98. 2019-11-20. PMID:25379028. |
in recent analyses, we found that tli serves as a predictor of the development of cannabis use disorder (cud) among young adults (kirisci et al., 2009). |
2019-11-20 |
2023-08-13 |
human |
| Pamela Sabioni, Bernard Le Fol. Psychosocial and pharmacological interventions for the treatment of cannabis use disorder. F1000Research. vol 7. 2019-11-20. PMID:29497498. |
cannabis use has been continuously increasing, and cannabis use disorder (cud) has become a public health issue. |
2019-11-20 |
2023-08-13 |
Not clear |
| Pamela Sabioni, Bernard Le Fol. Psychosocial and pharmacological interventions for the treatment of cannabis use disorder. F1000Research. vol 7. 2019-11-20. PMID:29497498. |
some psychosocial interventions have demonstrated the ability to reduce cannabis use; however, there are no pharmacotherapies approved for the treatment of cud. |
2019-11-20 |
2023-08-13 |
Not clear |
| Joseph Aloi, Harma Meffert, Stuart F White, Karina S Blair, Soonjo Hwang, Patrick M Tyler, Laura C Thornton, Kathleen I Crum, Kathryn O Adams, Abraham D Killanin, Francesca Filbey, Kayla Pope, R James R Blai. Differential dysfunctions related to alcohol and cannabis use disorder symptoms in reward and error-processing neuro-circuitries in adolescents. Developmental cognitive neuroscience. vol 36. 2019-11-15. PMID:30710868. |
however, work indicative of this has mostly been conducted in adults with alcohol and/or cannabis use disorder (i.e., aud and cud), with relatively little work in adolescent patients. |
2019-11-15 |
2023-08-13 |
Not clear |
| Rachel L Tomko, Amanda K Gilmore, Kevin M Gra. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine. Addictive behaviors. vol 85. 2019-11-05. PMID:29803870. |
relative to adults, adolescents are at greater risk of developing a cannabis use disorder (cud) and risk may be exacerbated by co-occurring depressive symptoms. |
2019-11-05 |
2023-08-13 |
Not clear |
| Rachel L Tomko, Amanda K Gilmore, Kevin M Gra. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine. Addictive behaviors. vol 85. 2019-11-05. PMID:29803870. |
secondary analyses were conducted using a sub-sample of adolescents with cud (n = 74) who participated in an 8-week randomized placebo-controlled clinical trial examining the efficacy of nac for cannabis cessation. |
2019-11-05 |
2023-08-13 |
Not clear |
| Jane Metrik, Rachel L Gunn, Kristina M Jackson, Alexander W Sokolovsky, Brian Borsar. Daily Patterns of Marijuana and Alcohol Co-Use Among Individuals with Alcohol and Cannabis Use Disorders. Alcoholism, clinical and experimental research. vol 42. issue 6. 2019-11-04. PMID:29656401. |
the study aims were to examine daily associations between marijuana and alcohol use and the extent to which the association differs as a function of cannabis use disorder (cud) and/or alcohol use disorder (aud) diagnosis. |
2019-11-04 |
2023-08-13 |
Not clear |
| Andrew M Kiselica, Amy Duhig, Ivan Montoya, Phil Skolnick, Jennifer Floyd, Cigi Byar. A Survey of Payer Perspectives on Cannabis Use Disorder. Substance use & misuse. vol 53. issue 13. 2019-10-28. PMID:29927691. |
cannabis use disorder (cud) as described/defined in dsm 5, is characterized by impaired control of marijuana use and related personal, health, and legal consequences. |
2019-10-28 |
2023-08-13 |
Not clear |
| Michael J Mason, Nikola M Zaharakis, Michael Russell, Victoria Childres. A pilot trial of text-delivered peer network counseling to treat young adults with cannabis use disorder. Journal of substance abuse treatment. vol 89. 2019-10-25. PMID:29706169. |
approximately 1.8 million young adults aged 18 to 25 had a cannabis use disorder (cud) in the past year. |
2019-10-25 |
2023-08-13 |
human |
| Brian J Sherman, Nathaniel L Baker, Lindsay M Squeglia, Aimee L McRae-Clar. Approach bias modification for cannabis use disorder: A proof-of-principle study. Journal of substance abuse treatment. vol 87. 2019-10-21. PMID:29471922. |
more effective treatments for cannabis use disorder (cud) are needed. |
2019-10-21 |
2023-08-13 |
Not clear |
| Amna Zehra, Jamie Burns, Christopher Kure Liu, Peter Manza, Corinde E Wiers, Nora D Volkow, Gene-Jack Wan. Cannabis Addiction and the Brain: a Review. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 13. issue 4. 2019-10-07. PMID:29556883. |
with a recent increase in the rates of cannabis use disorder (cud) and a decrease in the perceived risk of cannabis use, it is imperative to assess the addictive potential of cannabis. |
2019-10-07 |
2023-08-13 |
Not clear |
| Amna Zehra, Jamie Burns, Christopher Kure Liu, Peter Manza, Corinde E Wiers, Nora D Volkow, Gene-Jack Wan. Cannabis Addiction and the Brain: a Review. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 13. issue 4. 2019-10-07. PMID:29556883. |
here we review previous research on the acute and long-term effects of cannabis use on the brain and behavior, and find that the three-stage framework of addiction applies to cud in a manner similar to other drugs of abuse, albeit with some slight differences. |
2019-10-07 |
2023-08-13 |
Not clear |
| Daniel P Notzon, Meredith A Kelly, C Jean Choi, Martina Pavlicova, Amy L Mahony, Daniel J Brooks, John J Mariani, Frances R Levi. Open-label pilot study of injectable naltrexone for cannabis dependence. The American journal of drug and alcohol abuse. vol 44. issue 6. 2019-09-26. PMID:29420073. |
there are no fda-approved pharmacotherapies for cannabis use disorders (cud), despite the evaluation of numerous medications. |
2019-09-26 |
2023-08-13 |
human |